These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15498177)

  • 1. Barriers to Creutzfeldt-Jakob disease autopsies, California.
    Louie JK; Gavali SS; Belay ED; Trevejo R; Hammond LH; Schonberger LB; Vugia DJ
    Emerg Infect Dis; 2004 Sep; 10(9):1677-80. PubMed ID: 15498177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers to autopsy: Creutzfeldt-Jakob disease in New York state.
    Lillquist PP; Thomas N; Belay ED; Schonberger LB; Morse D
    Neuroepidemiology; 2006; 26(4):207-11. PubMed ID: 16645319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview and evaluation of 15 years of Creutzfeldt-Jakob disease surveillance in Belgium, 1998-2012.
    Litzroth A; Cras P; De Vil B; Quoilin S
    BMC Neurol; 2015 Dec; 15():250. PubMed ID: 26630984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creutzfeldt-Jakob disease surveillance in Argentina, 1997-2008.
    Begué C; Martinetto H; Schultz M; Rojas E; Romero C; D'Giano C; Sevlever G; Somoza M; Taratuto AL
    Neuroepidemiology; 2011; 37(3-4):193-202. PubMed ID: 22067221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic evaluation for Creutzfeldt-Jakob disease in Massachusetts, 1991-2001.
    Jara M; John B; Kreindel S; Wilk-Rivard E; DeMaria A
    Clin Infect Dis; 2005 Sep; 41(6):829-33. PubMed ID: 16107981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creutzfeldt-Jakob disease in Ireland: epidemiological aspects 1980-2002.
    Horan G; Keohane C; Molloy S; Howley R; Harney M; Heffernan J; McGuigan C; Hutchinson M; Brett F; Farrell M
    Eur Neurol; 2004; 51(3):132-7. PubMed ID: 14988606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance for Creutzfeldt-Jakob disease in China from 2006 to 2007.
    Shi Q; Gao C; Zhou W; Zhang BY; Chen JM; Tian C; Jiang HY; Han J; Xiang NJ; Wang XF; Gao YJ; Dong XP
    BMC Public Health; 2008 Oct; 8():360. PubMed ID: 18928564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease.
    Steinhoff BJ; Zerr I; Glatting M; Schulz-Schaeffer W; Poser S; Kretzschmar HA
    Ann Neurol; 2004 Nov; 56(5):702-8. PubMed ID: 15449324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of Creutzfeldt-Jakob disease in Australia: 2008.
    Klug GM; Boyd A; Lewis V; McGlade AR; Roberts H; Douglass SL; Masters CL; Collins SJ
    Commun Dis Intell Q Rep; 2008 Jun; 32(2):232-6. PubMed ID: 18767422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of administrative diagnostic data for pathologically confirmed cases of Creutzfeldt-Jakob disease in Massachusetts, 2000-2008.
    Barash JA; West JK; DeMaria A
    Am J Infect Control; 2014 Jun; 42(6):659-64. PubMed ID: 24721779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Eleven years of autopsy on account of Creutzfeldt-Jakob disease in the Netherlands].
    Jansen C; Schuur M; Spliet WG; van Gool WA; van Duijn CM; Rozemuller AJ
    Ned Tijdschr Geneeskd; 2009; 153():A172. PubMed ID: 19785859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance.
    Heinemann U; Krasnianski A; Meissner B; Varges D; Kallenberg K; Schulz-Schaeffer WJ; Steinhoff BJ; Grasbon-Frodl EM; Kretzschmar HA; Zerr I
    Brain; 2007 May; 130(Pt 5):1350-9. PubMed ID: 17472986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of Creutzfeldt-Jakob disease in Australia: 2010 update.
    Klug GM; Boyd A; McGlade A; Stehmann C; Masters CL; Collins SJ
    Commun Dis Intell Q Rep; 2010 Jun; 34(2):96-101. PubMed ID: 20677418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on the epidemiology and key issues associated with the diagnosis and management of Creutzfeldt-Jakob disease cases in NSW.
    Quinn E; Merritt T; Buckland ME; Tobin S
    Public Health Res Pract; 2014 Nov; 25(1):. PubMed ID: 25828448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can mortality data provide reliable indicators for Creutzfeldt-Jakob disease surveillance? A study in France from 2000 to 2008.
    Brandel JP; Welaratne A; Salomon D; Capek I; Vaillant V; Aouba A; Haïk S; Alpérovitch A
    Neuroepidemiology; 2011; 37(3-4):188-92. PubMed ID: 22057088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autopsy-proven Creutzfeldt-Jakob disease in a patient with a negative 14-3-3 assay and nonspecific EEG and MRI.
    Donahue JE; Hanna PA; Hariharan S
    Neurol Sci; 2004 Feb; 24(6):411-3. PubMed ID: 14767688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology and clinical symptomatology of Creutzfeldt-Jakob disease].
    Mollenhauer B; Zerr I; Ruge D; Krause G; Mehnert WH; Kretzschmar HA; Poser S
    Dtsch Med Wochenschr; 2002 Feb; 127(7):312-7. PubMed ID: 11845386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of Creutzfeldt-Jakob disease in Australia: 2009 update.
    Klug GM; Boyd A; Lewis V; McGlade A; Stehmann C; Masters CL; Collins SJ
    Commun Dis Intell Q Rep; 2009 Jun; 33(2):188-91. PubMed ID: 19877536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical diagnosis of Creutzfeldt-Jakob disease: accuracy based on analysis of autopsy-confirmed cases.
    Iwasaki Y; Mimuro M; Yoshida M; Sobue G; Hashizume Y
    J Neurol Sci; 2009 Feb; 277(1-2):119-23. PubMed ID: 19056094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence of Creutzfeldt-Jakob disease in France, 1992-1995].
    Ruffié A; Delasnerie-Lauprêtre N; Brandel JP; Jaussent I; Dormont D; Laplanche JL; Hauw JJ; Richardson S; Alpérovitch A
    Rev Epidemiol Sante Publique; 1997 Dec; 45(6):448-53. PubMed ID: 9496575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.